Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
Go back to Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 11.12 -0.2 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.32 | 52 Week High | $9.23 | |||
| Open | $11.02 | 52 Week Low | $1.16 | |||
| Day High | $11.42 | P/E | N/A | |||
| Day Low | $10.90 | EPS | $-0.30 | |||
| Volume | 557,031 | |||||



